APA

Peng L., Chen Y., Xu C., Tang L., Chen L., Lin A., Liu X., Sun Y. & Ma J. (20191213). A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma. : Oral oncology.

Chicago

Peng Liang, Chen Yu-Pei, Xu Cheng, Tang Ling-Long, Chen Lei, Lin Ai-Hua, Liu Xu, Sun Ying and Ma Jun. 20191213. A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma. : Oral oncology.

Harvard

Peng L., Chen Y., Xu C., Tang L., Chen L., Lin A., Liu X., Sun Y. and Ma J. (20191213). A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma. : Oral oncology.

MLA

Peng Liang, Chen Yu-Pei, Xu Cheng, Tang Ling-Long, Chen Lei, Lin Ai-Hua, Liu Xu, Sun Ying and Ma Jun. A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma. : Oral oncology. 20191213.